Kanagal-Shamanna, R., Jain, P., Takahashi, K., Short, N. J., Tang, G., Issa, G. C., . . . Jabbour, E. (2017). TP53 Mutation Does Not Confer a Poor Outcome in Adult ALL Treated with Frontline Hyper-CVAD-based Regimens. Cancer.
シカゴスタイル引用形Kanagal-Shamanna, Rashmi, et al. "TP53 Mutation Does Not Confer a Poor Outcome in Adult ALL Treated With Frontline Hyper-CVAD-based Regimens." Cancer 2017.
MLA引用形式Kanagal-Shamanna, Rashmi, et al. "TP53 Mutation Does Not Confer a Poor Outcome in Adult ALL Treated With Frontline Hyper-CVAD-based Regimens." Cancer 2017.
警告: この引用は必ずしも正確ではありません.